2361 — Sinohealth Holdings Balance Sheet
0.000.00%
- HK$1.69bn
- HK$965.50m
- CNY403.73m
- 97
- 51
- 43
- 74
Annual balance sheet for Sinohealth Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 472 | 407 | 587 | 468 | 560 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 29.6 | 82.9 | 94.4 | 97.9 | 99 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 507 | 500 | 702 | 609 | 668 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 30.8 | 13.5 | 11.2 | 18.6 | 15.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 542 | 517 | 796 | 798 | 811 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 55.3 | 96.1 | 97.8 | 84.3 | 92.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 79.5 | 100 | 101 | 94.4 | 100 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 463 | 417 | 695 | 703 | 711 |
| Total Liabilities & Shareholders' Equity | 542 | 517 | 796 | 798 | 811 |
| Total Common Shares Outstanding |